Resectable Non-Small-Cell Lung Cancer trials recruiting in California

Fewer than 3 recruiting trials found.

All Resectable Non-Small-Cell Lung Cancer trials nationally

Cities in California

Recruiting trials in California

• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
  NCT04198766 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Glendale, Los Angeles, Murrieta